General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA in silico strategy (Clinical Pharmacology and Therapeutics, 2019)

(untitled) - Li, Z; Mirams, GR; Yoshinaga, T; Ridder, BJ; Han, X; Chen, JE; Stockbridge, NL; Wisialowski, TA; Damiano, B; Severi, S; Morissette, P; Kowey, PR; et al.